Cantor Fitzgerald Reiterates Overweight Rating on ORIC Pharmaceuticals (ORIC) Sep 26, 2025 06:42AM
Cantor Fitzgerald Reiterates Overweight Rating on ORIC Pharmaceuticals (ORIC) May 29, 2025 06:42AM
Cantor Fitzgerald on ORIC Pharmaceuticals (ORIC): 'Solid Update in Prostate Cancer for ORIC-944' May 29, 2025 06:20AM
ORIC Pharmaceuticals Inc. (ORIC) Shares Continue Strength Follow Y'Day Sell side Comments, +6pct May 21, 2025 10:08AM
Cantor Fitzgerald Reiterates Overweight Rating on ORIC Pharamceuticals (ORIC) May 20, 2025 09:59AM


Feb 10, 2025 11:12AM Cantor Fitzgerald Reiterates Overweight Rating on ORIC Pharamceuticals (ORIC) Following Possible ASCO-GU Feb 13 News Title Leak
Feb 4, 2025 09:38AM Cantor Fitzgerald Reiterates Overweight Rating on ORIC Pharamceuticals (ORIC)
Feb 23, 2024 06:01AM Cantor Fitzgerald Starts ORIC Pharamceuticals (ORIC) at Overweight, 'offers attractive risk/reward'